High-mobility-group box chromosomal protein 1 as a new target for modulating stress response

Surgery Today

Volumn 40, Issue 7, 2010, Pages 592-601

  Suda, Koichi ^a   Takeuchi, Hiroya ^a   Ishizaka, Akitoshi ^a   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Alarmin; High mobility group box chromosomal protein 1; Multiple organ dysfunction syndrome; Pathogen associated molecular pattern; Stress response; Systemic inflammatory response syndrome

Indexed keywords

ACETYLCHOLINE; ANTITHROMBIN III; CHEMICAL COMPOUND; CHROMOSOME PROTEIN; CYTOKINE; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 A BOX PEPTIDE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; IMMUNOGLOBULIN; NAFAMSTAT; NICOTINE; PEPTIDE; PHOSPHATIDYLCHOLINE; PROTEIN; PROTEIN ANTIBODY; PYRUVIC ACID ETHYL ESTER; RAGE PROTEIN; RAGE PROTEIN ANTIBODY; RECOMBINANT THROMBOMODULIN; SIVELESTAT; STEAROYL LYSOPHOSPHATIDYLCHOLINE; TANSHINONE IIA; THROMBOMODULIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTHRITIS; CYTOKINE PRODUCTION; HUMAN; HYPOTHESIS; INFLAMMATION; MAJOR SURGERY; NONHUMAN; POSTOPERATIVE COMPLICATION; REVIEW; SEPSIS; SURGICAL STRESS; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

BIOLOGICAL MARKERS; HMGB1 PROTEIN; HUMANS; POSTOPERATIVE COMPLICATIONS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77955636468     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4232-1     Document Type: Review

References (126)

1. R.C. Bone R.A. Balk F.B. Cerra R.P. Dellinger A.M. Fein W.A. Knaus, et al. 1992 ACCP/SCCM Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Chest 101 1644 1655 1:STN:280:DyaK383ovFeiuw%3D%3D 1303622 10.1378/chest.101.6.1644
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit. Care Med 20 864 874 10.1097/00003246-199206000-00025
3. C.M. Robertson C.M. Coopersmith 2006 The systemic inflammatory response syndrome Microbes Infect 8 1382 1389 1:CAS:528:DC%2BD28XlsFOgsb8%3D 16679040 10.1016/j.micinf.2005.12.016 (Pubitemid 43831701)
4. N. Sato K. Koeda K. Ikeda Y. Kimura K. Aoki T. Iwaya, et al. 2002 Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer Ann Surg 236 184 190 12170023 10.1097/00000658- 200208000-00006 (Pubitemid 34809537)
5. N. Sato S. Endo Y. Kimura K. Ikeda K. Aoki T. Iwaya, et al. 2002 Influence of a human protease inhibitor on surgical stress induced immunosuppression Dig Surg 19 300 305 1:CAS:528:DC%2BD38Xms1ert78%3D 12207074 10.1159/000064578 (Pubitemid 35013736)
6. R.C. Bone 1996 Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation Crit Care Med 24 163 172 1:STN:280:DyaK287mtVOiuw%3D%3D 8565523 10.1097/00003246-199601000-00026 (Pubitemid 26151605)
7. R.A. Pixley S. Zellis P. Bankes R.A. DeLa Cadena J.D. Page C.F. Scott, et al. 1995 Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome Crit Care Med 23 41 51 1:STN:280:DyaK2M%2FpsVGguw%3D%3D 7528118 10.1097/00003246-199501000-00010
8. F.A. Moore E.E. Moore 1995 Evolving concepts in the pathogenesis of postinjury multiple organ failure Surg Clin North Am 75 257 277 1:STN:280:DyaK2M3gsl2jtw%3D%3D 7899997
9. M. Ogawa 1996 Mechanisms of the development of organ failure following surgical insult: The "second attack" theory Clin Intensive Care 7 34 38 10.1080/714028925
10. K.J. Tracey B. Beutler S.F. Lowry J. Merryweather S. Wolpe I.W. Milsark, et al. 1986 Shock and tissue injury induced by recombinant human cachectin Science 234 470 474 1:CAS:528:DyaL28XmtVCntbs%3D 3764421 10.1126/science.3764421
11. K.J. Tracey Y. Fong D.G. Hesse K.R. Manogue A.T. Lee G.C. Kuo, et al. 1987 Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 662 664 1:CAS:528:DyaL1cXlsVSktg%3D%3D 3317066 10.1038/330662a0 (Pubitemid 18005583)
12. C.A. Dinarello 1994 The interleukin-1 family: 10 years of discovery FASEB J 8 1314 1325 1:CAS:528:DyaK2MXislegsr4%3D 8001745
13. C.F. Nathan 1987 Secretory products of macrophages J Clin Invest 79 319 326 1:CAS:528:DyaL2sXhtFOlt7w%3D 3543052 10.1172/JCI112815
14. Y. Fong K.J. Tracey L.L. Moldawer D.G. Hesse K.B. Manogue J.S. Kenney, et al. 1989 Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia J Exp Med 170 1627 1633 1:CAS:528:DyaL1MXmtlSns7Y%3D 2809510 10.1084/jem.170.5.1627
15. N.C. Riedemann R.F. Guo P.A. Ward 2003 Novel strategies for the treatment of sepsis Nat Med 9 517 524 1:CAS:528:DC%2BD3sXjtlamt7Y%3D 12724763 10.1038/nm0503-517 (Pubitemid 36597096)
16. H. Yang M. Ochani J. Li X. Qiang M. Tanovic H.E. Harris, et al. 2004 Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 101 296 301 1:CAS:528:DC%2BD2cXjvFamtA%3D%3D 14695889 10.1073/pnas.2434651100 (Pubitemid 38084244)
17. H. Wang O. Bloom M. Zhang J.M. Vishnubhakat M. Ombrellino J. Che, et al. 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 248 251 1:CAS:528:DyaK1MXks1Sjtb0%3D 10398600 10.1126/science.285.5425.248 (Pubitemid 29329996)
18. L.L. Mantell W.R. Parrish L. Ulloa 2006 HMGB-1 as a therapeutic target for infectious and inflammatory disorders Shock 25 4 11 1:CAS:528: DC%2BD28XosVOntA%3D%3D 16369179 10.1097/01.shk.0000188710.04777.9e
19. G.H. Goodwin C. Sanders E.W. Johns 1973 A new group of chromatinassociated proteins with a high content of acidic and basic amino acids Eur J Biochem 38 14 19 1:CAS:528:DyaE2cXjsVGisQ%3D%3D 4774120 10.1111/j.1432-1033.1973.tb03026.x
20. H. Wang H. Yang K.J. Tracy 2004 Extracellular role of HMGB1 in inflammation and sepsis J Intern Med 255 320 331 1:CAS:528:DC%2BD2cXislKmtbo%3D 14871456 10.1111/j.1365-2796.2003.01302.x (Pubitemid 38324549)
21. J. Merenmies R. Pihlaskari J. Laitinen J. Wartiovaara H. Rauvala 1991 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane J Biol Chem 266 16722 16729 1:CAS:528: DyaK38Xlt1yltb4%3D 1885601
22. H. Rauvala H.J. Huttunen C. Fages M. Kaksonen T. Kinnunen S. Imai, et al. 2000 Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility Matrix Biol 19 377 387 1:CAS:528: DC%2BD3cXnt1aqt7Y%3D 10980414 10.1016/S0945-053X(00)00084-6
23. S. Prasad M.K. Thakur 1988 Age-dependent effects of sodium butyrate and hydrocortisone on acetylation of high mobility group proteins of rat liver Biochem Int 16 375 382 1:CAS:528:DyaL1cXhs1Wlt7s%3D 3365268
24. D. Landsman M. Bustin 1993 A signature for the HMG-1 box DNAbinding proteins Bioessays 15 539 546 1:CAS:528:DyaK2cXpvFGnsQ%3D%3D 8135767 10.1002/bies.950150807
25. M. Bustin 1999 Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins Mol Cell Biol 19 5237 5246 1:CAS:528:DyaK1MXkvVGqu7c%3D 10409715
26. M. Stros J. Reich 1998 Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA Eur J Biochem 251 427 434 1:CAS:528:DyaK1cXnvFSjsQ%3D%3D 9492314 10.1046/j.1432-1327.1998.2510427.x (Pubitemid 28080943)
27. M.E. Bianchi M. Beltrame G. Paonessa 1989 Specific recognition of cruciform DNA by nuclear protein HMG1 Science 243 1056 1059 1:CAS:528: DyaL1MXit1Ontrc%3D 2922595 10.1126/science.2922595
28. D.A. Hill M.L. Pedulla R. Reeves 1999 Directional binding of HMGI(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1 Nucleic Acids Res 27 2135 2144 1:CAS:528:DyaK1MXjsFGju7k%3D 10219086 10.1093/nar/27.10.2135 (Pubitemid 29219242)
29. D.A. Hill R. Reeves 1997 Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA Nucleic Acids Res 25 3523 3531 1:CAS:528: DyaK2sXlvFygtLc%3D 9254714 10.1093/nar/25.17.3523 (Pubitemid 27359231)
30. D. Locker M. Decoville J.C. Maurizot M.E. Bianchi M. Leng 1995 Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1:DNase I footprinting and circular dichroism J Mol Biol 246 243 247 1:CAS:528: DyaK2MXktVSgsbo%3D 7869375 10.1006/jmbi.1994.0079
31. S.A. Onate P. Prendergast J.P. Wagner M. Nissen R. Reeves D.E. Pettijohn, et al. 1994 The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences Mol Cell Biol 14 3376 3391 1:CAS:528:DyaK2cXjtFKjtbo%3D 8164686
32. J.H. Youn J.S. Shin 2006 Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion J Immunol 177 7889 7897 1:CAS:528:DC%2BD28Xht1WrsL3F 17114460
33. I. Ito J. Fukazawa M. Yoshida 2007 Posttranslational methylation of HMGB1 causes its cytoplasmic localization in neutrophils J Biol Chem 282 16336 16344 1:CAS:528:DC%2BD2sXlvVajt7s%3D 17403684 10.1074/jbc.M608467200 (Pubitemid 47100350)
34. T. Bonaldi F. Talamo P. Scaffidi D. Ferrera A. Porto A. Bachi, et al. 2003 Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it toward secretion EMBO J 22 5551 5560 1:CAS:528:DC%2BD3sXot1Crtrc%3D 14532127 10.1093/emboj/cdg516 (Pubitemid 37279964)
35. S. Calogero F. Grassi A. Aguzzi T. Volgtlander P. Ferrier S. Ferrari, et al. 1999 The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice Nat Genet 22 276 280 1:CAS:528:DyaK1MXkt1eqsbk%3D 10391216 10.1038/10338 (Pubitemid 29297255)
36. P. Matzinger 1994 Tolerance, danger, and the extended family Annu Rev Immunol 12 991 1045 1:STN:280:DyaK2c3otVOqsA%3D%3D 8011301
37. P. Matzinger 2002 The danger model: a renewed sense of self Science 296 301 305 1:CAS:528:DC%2BD38XjtVWiurk%3D 11951032 10.1126/science.1071059 (Pubitemid 34303674)
38. M.E. Bianchi 2007 DAMPs, PAMPs and alarmins: all we need to know about danger J Leukoc Biol 81 1 5 1:CAS:528:DC%2BD2sXktVaisg%3D%3D 17032697 10.1189/jlb.0306164 (Pubitemid 46028489)
39. R. Medzhitov C.A. Janeway Jr 2002 Decoding the patterns of self and nonself by the innate immune system Science 296 298 300 1:CAS:528: DC%2BD38XjtVWiurg%3D 11951031 10.1126/science.1068883 (Pubitemid 34303673)
40. R. Medzhitov C.A. Janeway Jr 1997 Innate immunity: the virtues of a nonclonal system of recognition Cell 91 295 298 1:CAS:528:DyaK2sXnt1Clsrw%3D 9363937 10.1016/S0092-8674(00)80412-2 (Pubitemid 27467959)
41. E.J. DeMaria J.V. Pellicane R.B. Lee 1993 Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor J Trauma 35 720 724 1:STN:280:DyaK2c%2Fkslahsw%3D%3D 8230336 10.1097/00005373-199311000-00012
42. K.P. Mollen R.J. Anand A. Tsung J.M. Prince R.M. Levy T.R. Billiar 2006 Emerging paradigm: tolllike receptor 4-sentinel for the detection of tissue damage Shock 26 430 437 1:CAS:528:DC%2BD28Xht1eht7vP 17047512 10.1097/01.shk.0000228797.41044.08 (Pubitemid 44632271)
43. P. Scaffidi T. Misteli M.E. Bianchi 2002 Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 191 195 1:CAS:528:DC%2BD38XltFGlsro%3D 12110890 10.1038/nature00858 (Pubitemid 34773774)
44. M.T. Lotze K.J. Tracey 2005 High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 331 42 1:CAS:528:DC%2BD2MXivVarsr8%3D 15803152 10.1038/nri1594 (Pubitemid 40516158)
45. E. Abraham J. Arcaroli A. Carmody H. Wang K.J. Tracey 2000 HMG-1 as a mediator of acute lung inflammation. J Immunol 165 2950 2954 1:CAS:528:DC%2BD3cXmslyns7g%3D
46. W. Jiang D.S. Pisetsky 2006 The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinicpolycytidylic acid or lipopolysaccharide J. Immunol 177 3337 3343 1:CAS:528: DC%2BD28Xot1CjtL4%3D 16920974
47. B. Rendon-Mitchell M. Ochani J. Li J. Han H. Wang H. Yang, et al. 2003 IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J Immunol 170 3890 3897 1:CAS:528:DC%2BD3sXitFKlurY%3D 12646658
48. A. Rouhiainen J. Kuja-Panula E. Wilkman J. Pakkanen J. Stenfors R.K. Tuominen, et al. 2004 Regulation of monocyte migration by amphoterin (HMGB1) Blood 104 1174 3882 1:CAS:528:DC%2BD2cXmslKgsbo%3D 15130941 10.1182/blood-2003- 10-3536 (Pubitemid 39038040)
49. D. Tang Y. Shi R. Kang F. Li W. Xiao H. Wang, et al. 2007 Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 J Leukoc Biol 81 741 747 1:CAS:528:DC%2BD2sXisFCmtrY%3D 17135572 10.1189/jlb.0806540 (Pubitemid 46393551)
50. H. Wahamaa T. Vallerskoq S. Qin C. Lunderius G. LaRosa U. Andersson, et al. 2007 HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay J Leukoc Biol 81 129 136 16980509 10.1189/jlb.0506349 1:CAS:528:DC%2BD2sXktVahtA%3D%3D (Pubitemid 46021261)
51. O. Hori J. Brett T. Slattery R. Cao J. Zhang J.X. Chen, et al. 1995 The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system J Biol Chem 270 25752 25761 1:CAS:528:DyaK2MXovFyks7s%3D 7592757 10.1074/jbc.270.43.25752
52. J.S. Park D. Svetkauskaite H. He J. Kim D. Strassheim A. Ishizaka, et al. 2004 Involvement of TLR2 and TLR4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 7370 7376 1:CAS:528:DC%2BD2cXhsFaqurc%3D 14660645 10.1074/jbc.M306793200 (Pubitemid 38294612)
53. J.S. Park F. Gamboni-Robertson Q. He D. Svetkauskaite J.Y. Kim D. Strassheim, et al. 2006 High mobility group box 1 protein interacts with multiple Toll-like receptors Am J Physiol Cell Physiol 290 C917 C924 1:CAS:528:DC%2BD28Xjt1Slu7g%3D 16267105 10.1152/ajpcell.00401.2005
54. R. Palumbo B.G. Galvez T. Pusterla F. De Marchis G. Cossu K.B. Marcu, et al. 2007 Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation J Cell Biol 179 33 40 1:CAS:528:DC%2BD2sXhtFOntbzP 17923528 10.1083/jcb.200704015 (Pubitemid 47606681)
55. J.S. Park J. Arcaroli H.K. Yum H. Yang H. Wang K.Y. Yang, et al. 2003 Activation of gene expression in human neutrophils by high mobility group box 1 protein Am J Physiol Cell Physiol 284 C870 C879 1:CAS:528:DC%2BD3sXjsVSntrs%3D 12620891
56. D. Messmer H. Yang G. Telusma F. Knoll J. Li B. Messmer, et al. 2004 High mobility group box protein 1:an endogenous signal for dendritic cell maturation and Th1 polarization J Immunol 173 307 313 1:CAS:528:DC%2BD2cXltVaju7k%3D 15210788
57. I.E. Dumitriu P. Barnah B. Valentinis R.E. Voll M. Herrmann P.P. Nawroth, et al. 2005 Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products J Immunol 174 7506 7515 1:CAS:528:DC%2BD2MXkvVOmt74%3D 15944249
58. G. Telusma S. Datta I. Mihajlov W. Ma J. Li H. Tang, et al. 2006 Dendritic cell activating peptides induce distinct cytokine profiles Int Immunol 18 1563 1573 1:CAS:528:DC%2BD28XhtFaktr3F 16966494 10.1093/intimm/dxl089 (Pubitemid 44605577)
59. D. Yang Q. Chen H. Yang K.J. Tracey M. Bustin J.J. Oppenheim, et al. 2007 High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin J Leukoc Biol 81 59 66 1:CAS:528:DC%2BD2sXktVaiug%3D%3D 16966386 10.1189/jlb.0306180 (Pubitemid 46021253)
60. I.E. Dumitriu P. Baruah M.E. Bianchi A.A. Manfredi P. Rovere-Querini 2005 Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells Eur J Immunol 35 2184 2190 1:CAS:528:DC%2BD2MXmvVeju7Y%3D 15915542 10.1002/eji.200526066 (Pubitemid 41015057)
61. I.E. Dumitriu M.E. Bianchi M. Bacci A.A. Manfredi P. Rovere-Querini 2007 The secretion of HMGB1 is required for the migration of maturing dendritic cells J Leukoc Biol 81 84 91 1:CAS:528:DC%2BD2sXktVahsw%3D%3D 17035340 10.1189/jlb.0306171 (Pubitemid 46021256)
62. V.V. Orlova E.Y. Choi C. Xie E. Chavakis A. Bierhaus E. Ihanus, et al. 2007 A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin EMBO J 26 1129 1139 1:CAS:528:DC%2BD2sXhvFWlu7c%3D 17268551 10.1038/sj.emboj.7601552
63. C. Fiuza M. Bustin S. Talwar M. Tropea E. Gerstenberger J.H. Shelhamer, et al. 2003 Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2652 2660 1:CAS:528:DC%2BD3sXivVWgu7k%3D 12456506 10.1182/blood-2002-05-1300 (Pubitemid 36857626)
64. C.J. Treutiger G.E. Mullins A.S. Johansson A. Rouhiainen H.M. Raurola H. Erlandsson-Harris, et al. 2003 High mobility group 1 B-box mediates activation of human endothelium J Intern Med 254 375 385 1:CAS:528:DC%2BD3sXoslOmsro%3D 12974876 10.1046/j.1365-2796.2003.01204.x (Pubitemid 37211261)
65. A. Tsung N. Zheng G. Jeyabalan K. Izuishi J.R. Klune D.A. Geller, et al. 2007 Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury J Leukoc Biol 81 119 128 1:CAS:528: DC%2BD2sXktVahtw%3D%3D 17062605 10.1189/jlb.0706468 (Pubitemid 46021260)
66. C.F. Nathan 1987 Secretory products of macrophages J Clin Invest 79 319 326 1:CAS:528:DyaL2sXhtFOlt7w%3D 3543052 10.1172/JCI112815
67. U. Andersson H. Wang K. Palmblad A.C. Aveberger O. Bloom H. Erlandsson-Harris, et al. 2000 HMG-1 stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 565 570 1:CAS:528: DC%2BD3cXlvFemsL0%3D 10952726 10.1084/jem.192.4.565
68. D. Stern S.D. Yan S.F. Yan A.M. Schmidt 2002 Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings Adv Drug Deliv Rev 54 1615 1625 1:CAS:528: DC%2BD38XovFemtL0%3D 12453678 10.1016/S0169-409X(02)00160-6
69. B. Degryse T. Bonaldi P. Scaffidi S. Muller M. Resnati F. Sanvito, et al. 2001 The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells J Cell Biol 152 1197 1206 1:CAS:528:DC%2BD3MXit1egt78%3D 11257120 10.1083/jcb.152.6. 1197
70. K. Suda Y. Kitagawa S. Ozawa Y. Saikawa M. Ueda M. Ebina, et al. 2006 Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis World J Surg 30 1755 1762 16850155 10.1007/s00268-005-0369-2
71. M. Ombrellino H. Wang M.S. Ajemian A. Talhouk L.A. Scher S.G. Friedman, et al. 1999 Increased serum concentrations of highmobility-group protein 1 in hemorrhagic shock Lancet 354 1446 1447 1:STN:280:DC%2BD3c%2FgvFShsQ%3D%3D 10543678 10.1016/S0140-6736(99)02658-6
72. J.Y. Kim J.S. Park D. Strassheim I. Douglas F. Diaz del Valle K. Asehnoune, et al. 2005 HMGB1 contributes to the development of acute lung injury after hemorrhage Am J Physiol Lung Cell Mol Physiol 288 L958 L965 1:CAS:528:DC%2BD2MXktlSntLY%3D 15640285 10.1152/ajplung.00359.2004
73. R. Yang T. Harada K.P. Mollen J.M. Prince R.M. Levy J.A. Englert, et al. 2006 Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock Mol Med 12 105 114 1:CAS:528:DC%2BD28XhtFSju7nF 16953558 10.2119/2006-00010.Yang
74. R.M. Levy K.P. Mollen J.M. Prince D.J. Kaczorowski R. Vallabhaneni S. Liu, et al. 2007 Systemic inflammation and remote organ injury following trauma require HMGB1 Am J Physiol Regul Integr Comp Physiol 293 R1538 R1544 1:CAS:528:DC%2BD2sXht1Wlu73M 17652366
75. A. Tsung R. Sahai H. Tanaka A. Nakao M.P. Fink M.T. Lotze, et al. 2005 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 1135 1143 1:CAS:528:DC%2BD2MXjtFWls7s%3D 15795240 10.1084/jem.20042614
76. R.S. Goldstein M. Gallowitsch-Puerta L. Yang M. Rosas-Ballina J.M. Huston C.J. Czura, et al. 2006 Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia Shock 25 571 574 1:CAS:528: DC%2BD28XlvVenu7o%3D 16721263 10.1097/01.shk.0000209540.99176.72
77. J. Oyama C. Blais Jr X. Liu M. Pu L. Kobzik R.A. Kelly, et al. 2004 Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice Circulation 109 784 789 1:CAS:528:DC%2BD2cXhtFWltbw%3D 14970116 10.1161/01.CIR.0000112575.66565.84
78. H. Wu G. Chen K.R. Wyburn J. Yin P. Bertolino J.M. Eris, et al. 2007 TLR4 activation mediates kidney ischemia/reperfusion injury J Clin Invest 117 2847 2859 1:CAS:528:DC%2BD2sXhtFCnt73E 17853945 10.1172/JCI31008
79. G. Faraco S. Fossati M.E. Bianchi M. Patrone M. Pedrazzi B. Sparatore, et al. 2007 High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo J Neurochem 103 590 603 1:CAS:528:DC%2BD2sXht1KqsL3N 17666052 10.1111/j.1471-4159.2007.04788.x
80. T. Hatada H. Wada T. Nobori K. Okabayashi K. Maruyama Y. Abe, et al. 2005 Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation Thromb Haemost 94 975 979 1:CAS:528:DC%2BD2MXht1Kgt7zF 16363239
81. T. Ito K. Kawahara T. Nakamura S. Yamada K. Abeyama T. Hashiguchi, et al. 2007 High-mobility group box 1 protein promotes development of microvascular thrombosis in rats J Thromb Haemost 5 109 116 1:CAS:528:DC%2BD2sXhsFyiurw%3D 17239166 10.1111/j.1538-7836.2006.02255.x
82. K. Suda Y. Kitagawa S. Ozawa Y. Saikawa M. Ueda E. Abraham, et al. 2006 Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery? Dis Esophagus 19 5 9 1:STN:280: DC%2BD2Mnns1ykuw%3D%3D 16364036 10.1111/j.1442-2050.2006.00529.x
83. H. Ueno T. Matsuda S. Hashimoto F. Amaya Y. Kitamura M. Tanaka, et al. 2004 Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 170 1310 1316 15374839 10.1164/rccm.200402-188OC
84. W. Lutz J. Stetkiewicz 2004 High mobility group box 1 protein as a late-acting mediator of acute lung inflammation Int J Occup Med Environ Health 17 245 254 15387080
85. E.N. Ogawa A. Ishizaka S. Tasaka H. Koh H. Ueno F. Amaya, et al. 2006 Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury Am J Respir Crit Care Med 174 400 407 1:CAS:528:DC%2BD28XpsVeru7s%3D 16728713 10.1164/rccm.200605-699OC
86. A. Tajima M. Kohno M. Watanabe Y. Izumi S. Tasaka I. Maruyama, et al. 2008 Occult injury in the residual lung after pneumonectomy in mice Interact Cardiovasc Thorac Surg 7 1114 1120 18713778 10.1510/icvts.2007.170456
87. T. Kohno T. Anzai K. Naito T. Miyasho M. Okamoto H. Yokota, et al. 2009 Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling Cardiovasc Res 81 565 573 1:CAS:528: DC%2BD1MXhtlKitbs%3D 18984601 10.1093/cvr/cvn291
88. A. Porto R. Palumbo M. Pieroni G. Aprigliano R. Chiesa F. Sanvito, et al. 2006 Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein FASEB J 20 E1955 E1963 10.1096/fj.06-5867fje 1:CAS:528:DC%2BD28Xht1ymtbbI
89. N. Taniguchi K. Kawahara K. Yone M. Hashiguchi M. Goto 2003 High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine Arthritis Rheum 48 971 981 1:CAS:528: DC%2BD3sXjtlKnsrk%3D 12687539 10.1002/art.10859
90. R. Kokkola E. Sundberg A.-K. Ulfgren K. Palmblad J. Li H. Wang, et al. 2002 High mobility group box chromosomal protein 1 (HMGB1) - a novel pro-inflammatory mediator in synovitis Arthritis Rheum 46 2598 2603 1:CAS:528:DC%2BD38XovVWitrw%3D 12384917 10.1002/art.10540
91. R. Pullerits I.M. Jonsson M. Verdrengh M. Bokarewa U. Andersson H. Erlandsson-Harris, et al. 2003 High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis Arthritis Rheum 48 1693 1700 1:CAS:528:DC%2BD3sXltlSgu7s%3D 12794838 10.1002/art.11028
92. R. Kokkola J. Li E. Sundberg A.C. Aveberger K. Palmblad H. Yang, et al. 2003 Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity Arthritis Rheum 48 2052 2058 1:CAS:528:DC%2BD3sXmtFartbc%3D 12847700 10.1002/art.11161
93. L. Ulloa F.M. Batliwalla U. Andersson P.K. Gregersen K.J. Tracey 2003 High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis Arthritis Rheum 48 876 881 1:CAS:528:DC%2BD3sXjtlKnsrw%3D 12687528 10.1002/art.10854
94. D. Agnello H. Wang H. Yang K.J. Tracey P. Ghezzi 2002 HMGB1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion Cytokine 18 231 236 1:CAS:528:DC%2BD38XltFyrurs%3D 12126646 10.1006/cyto.2002.0890
95. K.A. O'Connor M.K. Hansen P.C. Rachal M.M. Deak J.C. Biedenkapp E.D. Milligan, et al. 2003 Further characterization of high mobility group box 1 as a proinflammatory cytokine: central nervous system effects Cytokine 24 254 265 14609567 10.1016/j.cyto.2003.08.001 1:CAS:528:DC%2BD3sXovVeiurs%3D
96. K. Liu S. Mori H.K. Takahashi Y. Tomono H. Wake T. Kanke, et al. 2007 Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats FASEB J 21 3904 3916 1:CAS:528: DC%2BD2sXhsVahtbrN 17628015 10.1096/fj.07-8770com
97. P.L. Sappington R. Yang H. Yang K.J. Tracey R.L. Delude M.P. Fink 2002 HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice Gastroenterology 123 790 802 1:CAS:528:DC%2BD38XnsVWhu7s%3D 12198705 10.1053/gast.2002.35391
98. S. Maeda Y. Hikiba W. Shibata T. Ohmae A. Yanai K. Ogura, et al. 2007 Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer Biochem Biophys Res Commun 360 394 400 1:CAS:528:DC%2BD2sXnslSqtb8%3D 17599806 10.1016/j.bbrc.2007.06.065
99. T. Yasuda T. Ueda Y. Takeyama M. Shinzeki H. Sawa T. Nakajima, et al. 2006 Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis Pancreas 33 359 363 1:CAS:528:DC%2BD28Xht1Cms7nE 17079940 10.1097/01.mpa.0000236741.15477.8b
100. M.E. Bianchi A.A. Manfredi 2007 High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity Immunol Rev 220 35 46 1:CAS:528:DC%2BD2sXhsVKgtr3J 17979838 10.1111/j.1600-065X.2007.00574.x
101. J. Li R. Kokkola S. Tabibzadeh R. Yang M. Ochani X. Qiang, et al. 2003 Structural basis for the proinflammatory cytokine activity of high mobility group box 1 Mol Med 9 37 45 1:CAS:528:DC%2BD3sXls1CisLk%3D 12765338
102. B. Degryse T. Bonaldi P. Scaffidi S. Muller M. Resnati F. Sanvito, et al. 2001 The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells J Cell Biol 152 1197 1206 1:CAS:528:DC%2BD3MXit1egt78%3D 11257120 10.1083/jcb.152.6. 1197
103. R. Palumbo M. Sampaolesi F. DeMarchis R. Tonlorenzi S. Colombetti A. Mondino, et al. 2004 Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation J Cell Biol 164 441 449 1:CAS:528:DC%2BD2cXhtVahsrg%3D 14744997 10.1083/jcb.200304135
104. E. Chavakis A. Hain M. Vinci G. Carmona M.E. Bianchi P. Vajkoczy, et al. 2007 High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells Circ Res 100 204 212 1:CAS:528:DC%2BD2sXhtVOrurc%3D 17218606 10.1161/01.RES.0000257774.55970.f4
105. F. Limana A. Germani A. Zacheo J. Kajstura A. Di Carlo G. Borsellino, et al. 2005 Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit cell proliferation and differentiation Circ Res 97 e73 e83 1:CAS:528:DC%2BD2MXhtVymt7bN 16166556 10.1161/01.RES.0000186276.06104.04
106. S. Straino A. Di Carlo A. Mangoni R. De Mori L. Guerra R. Maurelli, et al. 2008 High-mobility group box 1 protein in human and murine skin: involvement in wound healing J Invest Dermatol 128 1545 1553 1:CAS:528:DC%2BD1cXlvVSktb8%3D 18239618 10.1038/sj.jid.5701212
107. P.B. Beeson 1946 Development of torelance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade Proc Soc Exp Biol Med 61 248 250
108. K. Izuishi A. Tsung G. Jeyabalan N.D. Critchlow J. Li K.J. Tracey, et al. 2006 Cutting edge: highmobility group box 1 preconditioning protects against liver ischemia-reperfusion injury J Immunol 176 7154 7158 1:CAS:528: DC%2BD28Xlt1CltLk%3D 16751357
109. J.E. Ellerman C.K. Brown M. de Vera H.J. Zeh T. Billiar A. Rubartelli, et al. 2007 Masquerader: high mobility group box-1 and cancer Clin Cancer Res 13 2836 2848 1:CAS:528:DC%2BD2sXlt1Krsr4%3D 17504981 10.1158/1078-0432.CCR-06-1953
110. K. Abeyama D.M. Stern Y. Ito K. Kawahara Y. Yoshimoto M. Tanaka, et al. 2005 The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism J Clin Invest 115 1267 1274 1:CAS:528:DC%2BD2MXktFSkt7Y%3D 15841214
111. C. Esmon 2005 Do-all receptor takes on coagulation, inflammation Nat Med 11 475 477 1:CAS:528:DC%2BD2MXjvVOmu7g%3D 15875050 10.1038/nm0505-475
112. E.C. Lutterloh S.M. Opal D.D. Pittman J.C. Keith Jr X.Y. Tan B.M. Clancy, et al. 2007 Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection Crit Care 11 R122 18042296 10.1186/cc6184
113. L.E. Hanford J.J. Enghild Z. Valnickova S.V. Petersen L.M. Schaefer T.M. Schaefer, et al. 2004 Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) J Biol Chem 279 50019 50024 1:CAS:528:DC%2BD2cXhtVWjs7rK 15381690 10.1074/jbc.M409782200
114. T. Ito K. Kawahara K. Okamoto S. Yamada M. Yasuda H. Imaizumi, et al. 2008 Proteolytic cleavage of high mobility group box 1 protein by thrombn-thrombomodulin complexes Arterioscler Thromb Vasc Biol 28 1825 1830 1:CAS:528:DC%2BD1cXhtFSmsrnL 18599803 10.1161/ATVBAHA.107.150631
115. L. Ulloa M. Ochani H. Yang M. Tanovic D. Halperin R. Yang, et al. 2002 Ethyl pyruvate protects lethality in mice with established lethal sepsis and systemic inflammation Proc Natl Acad Sci USA 99 12351 12356 1:CAS:528: DC%2BD38XntlCksb8%3D 12209006 10.1073/pnas.192222999
116. H. Wang H. Liao M. Ochani M. Justiniani X. Lin L. Yang, et al. 2004 Cholinergic agonists inhibit HMGB-1 release and improve survival in experimental sepsis Nat Med 10 1216 1221 1:CAS:528:DC%2BD2cXptVOgtr8%3D 15502843 10.1038/nm1124
117. G. Chen J. Li X. Qiang C.J. Czura M. Ochani K. Ochani, et al. 2005 Suppression of HMGB-1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis J Lipid Res 46 623 627 1:CAS:528:DC%2BD2MXksFagtb8%3D 15687351 10.1194/jlr.C400018-JLR200
118. W. Li J. Li M. Ashok R. Wu D. Chen L. Yang, et al. 2007 A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1 J Immunol 178 3856 3864 1:CAS:528:DC%2BD2sXisVGjt7w%3D 17339485
119. L. Mollica F. De Marchis A. Spitaleri C. Dallacosta D. Pennacchini M. Zamai, et al. 2007 Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities Chem Biol 14 431 441 1:CAS:528: DC%2BD2sXkslaitbc%3D 17462578 10.1016/j.chembiol.2007.03.007
120. K. Suda Y. Kitagawa S. Ozawa T. Miyasho M. Okamoto Y. Saikawa, et al. 2007 Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy Dis Esophagus 20 478 486 1:STN:280: DC%2BD2snjsV2hsQ%3D%3D 17958722 10.1111/j.1442-2050.2007.00699.x
121. S. Hagiwara H. Iwasaka K. Togo T. Noguchi 2008 A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxininduced shock in rats by inhibiting HMGB1 Inflammation 31 227 234 1:CAS:528:DC%2BD1cXos1Wmt7g%3D 18536984 10.1007/s10753-008-9069-z
122. S. Hagiwara H. Iwasaka T. Noguchi 2007 Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury J Anesth 21 164 170 17458645 10.1007/s00540-006-0468-8
123. S. Hagiwara H. Iwasaka S. Matsumoto T. Noguchi 2008 High dose antithrombin III inhibits HMGB1 and improves endotoxininduced acute lung injury in rats Intensive Care Med 34 218 221 10.1007/s00134-007-0888-4
124. S. Hagiwara H. Iwasaka A. Hasegawa N. Asai T. Noguchi 2008 Highdose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis Intensive Care Med 34 1812 1819 1:CAS:528:DC%2BD1cXhtlamtrfI 18500418 10.1007/s00134-008-1161-1
125. Y. Sakamoto K. Mashiko H. Matsumoto Y. Hara N. Kutsukata Y. Yamamoto 2007 Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients ASAIO J 53 324 328 1:CAS:528:DC%2BD2sXlt1Cgur8%3D 17515723 10.1097/MAT.0b013e3180340301
126. H.E. Harris A. Raucci 2006 Alarmin(g) news about danger: workshop on innate danger signals and HMGB1 EMBO Reports 7 774 778 1:CAS:528: DC%2BD28XnsFajsrs%3D 16858429